Sildenafil Citrate
Product Images NDC 67296-1488

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 67296-1488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Label for Sildenafil Tablets USP 20 mg, showing a red box with the product name and strength prominently. The label includes storage instructions, dosage note, quantity of 1,000 tablets, and states it is Rx only. Distributed by TruPharma, LLC and manufactured by Rubicon Research Private Limited, India. The label displays multiple barcodes and regulatory information.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Label for Sildenafil Tablets USP 20 mg, containing 90 film-coated tablets. Distributed by TruPharma, LLC, Tampa, FL, and manufactured by Rubicon Research Private Limited, Maharashtra, India. Includes storage instructions, dosage note, and a barcode. The label features a prominent red box with product name and strength.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

A line graph showing estimated cumulative mortality rate (%) over a 5-year period. The graph compares three different dose levels labeled High Dose, Medium Dose, and Low Dose, with corresponding stepwise increasing mortality rates. The x-axis represents time in years, and the y-axis shows the estimated cumulative mortality rate percentage. The number of subjects at risk is noted above the graph for each dose category at several time points.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

A forest plot chart showing drug interactions with Sildenafil Citrate as measured by fold change and 90% confidence intervals in AUC and Cmax for various interacting drugs including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. Recommendations on dose adjustments or coadministration are provided alongside each drug.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

A chart showing the fold change with 90% confidence intervals in pharmacokinetic parameters (such as INR AUC, INR Cmax, AUC, and Cmax) of Sildenafil Citrate when coadministered with various interacting drugs. The chart includes drugs like Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin at different doses, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide with corresponding dose adjustment recommendations.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

A line chart showing the change from baseline (meters) over 12 weeks of study for Sildenafil Citrate at doses of 20mg, 40mg, and 80mg TID and placebo. Data points with error bars depict changes at weeks 4, 8, and 12 for each treatment group, illustrating progression over time.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

A forest plot chart depicting placebo-corrected changes in 6-minute walk distance (meters) for Sildenafil 20 mg TID across various subgroups. The graph includes baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean PAP, and PVRI categories with confidence intervals for each subgroup's effect estimate.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

A Kaplan-Meier survival curve chart comparing the percentage without a clinically worsening event between placebo and Sildenafil over 112 days from randomization. The y-axis shows the percentage without worsening, and the x-axis shows days from randomization. Two lines represent placebo and Sildenafil groups, with Sildenafil showing higher percentages without worsening over time.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

A line graph depicting the mean change from baseline in meters on the y-axis over weeks 4, 8, and 12 on the x-axis for Sildenafil Citrate at 1mg, 5mg, and 20mg TID doses. The graph includes error bars representing standard error for each treatment dose at each time point.*

FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

Chemical structure of Sildenafil Citrate showing its molecular framework including sulfonamide, pyrazolo-pyrimidinone core, and citrate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.